FOR IMMEDIATE RELEASE | Tue Jan 12 15:42:03 EST 2010

Media, small businesses invited to ACS Webinar about crowdsourcing, innovation and science

WASHINGTON, Jan. 12, 2010 — News media, scientists and others interested in finance, entrepreneurships and the chemical sciences are invited to join an American Chemical Society (ACS) Small & Medium Business Webinar on exploring the future of science in a crowd-sourced world.

Scheduled for Thursday, Jan. 21, 2 – 3 p.m. EST, the free Webinar, ”How Can Crowdsourcing in Chemistry Benefit ME?” will feature chemist and entrepreneur Alpheus Bingham, Ph.D., co-founder of InnoCentive, Inc., and strong supporter of open innovation..

Among the topics Bingham will cover are:

  • What is crowdsourcing and how skill needs change in a crowd-sourced world?
  • Why experts still live at the core of innovation.
  • What might the expert/non-expert boundary look like and how is it crossed?
  • How will open innovation shape the future of science?

In addition to InnoCentive, Inc., he has founded other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, and Chorus and Collaborative Drug Discovery, Inc. He had more than 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. He also has held positions as managing director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice president of R&D strategy. He received a B.S. in chemistry from Brigham Young University and a Ph.D. in organic chemistry from Stanford University.

The Small & Medium Business series, part of the ACS Webinars program, features industry experts and luminaries that address business topics on issues faced by scientists, entrepreneurs, and executives in small/med companies. There will be a 30-minute presentation by Bingham followed by a Q & A session.

News media and scientists can tune into the conference without charge, but must register in advance.

###